Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

GM Helix Implant,Ti,3.5X16: medical device reports filed with FDA

975 reports name it, 2019–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

975
device reports naming the brand
0% of all MAUDE reports · about 145 a year
349
reports, 12 months to August 2026
229 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 975 reports that name the brand "GM Helix Implant,Ti,3.5X16" (endosseous dental implant), received between October 2019 and August 2026; the manufacturer given most often on reports is Jjgc. Spellings of one product vary from report to report.

349 reports arrived in the 12 months to August 2026, up 52% from 229 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (74.8%), loss of osseointegration (13.5%) and difficult to insert (1.6%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02447Sep 2021: 1Oct 2021: 4Nov 2021: 3Dec 2021: 62022Jan 2022: 2Feb 2022: 6Mar 2022: 20Apr 2022: 5May 2022: 9Jun 2022: 5Jul 2022: 8Aug 2022: 10Sep 2022: 9Oct 2022: 6Nov 2022: 6Dec 2022: 152023Jan 2023: 13Feb 2023: 11Mar 2023: 25Apr 2023: 10May 2023: 5Jun 2023: 25Jul 2023: 7Aug 2023: 10Sep 2023: 11Oct 2023: 10Nov 2023: 7Dec 2023: 82024Jan 2024: 10Feb 2024: 8Mar 2024: 17Apr 2024: 15May 2024: 8Jun 2024: 13Jul 2024: 19Aug 2024: 24Sep 2024: 21Oct 2024: 18Nov 2024: 7Dec 2024: 262025Jan 2025: 17Feb 2025: 22Mar 2025: 12Apr 2025: 16May 2025: 0Jun 2025: 40Jul 2025: 18Aug 2025: 32Sep 2025: 19Oct 2025: 19Nov 2025: 47Dec 2025: 342026Jan 2026: 20Feb 2026: 38Mar 2026: 26Apr 2026: 19May 2026: 29Jun 2026: 26Jul 2026: 30Aug 2026: 42

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01382762019: 320192020: 1020202021: 2720212022: 10120222023: 14220232024: 18620242025: 27620252026: 2302026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%975
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report80%780
Voluntary report0%0
User facility report0%0
Distributor report20%195
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate72974.8%62.8%
Loss of osseointegration13213.5%22.4%
Difficult to insertthe device was hard to insert161.6%0.4%
Fracturea broken bone121.2%1.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis22823.4%
Painpain, site not specified22823.4%
Inflammationinflammation656.7%
Swelling/ edema373.8%
Fistula363.7%
Abscessa collection of pus313.2%
Hemorrhage/blood loss/bleeding313.2%
Hyperresponsive to stimuli141.4%
Numbnessnumbness90.9%
Hypersensitivity/allergic reaction80.8%
Sinus perforation20.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureGM Helix Implant,Ti,3.5X16Product code DZEAll MAUDE reports
Reports9753,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer80%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about GM Helix Implant,Ti,3.5X16 reports

How many FDA reports name GM Helix Implant,Ti,3.5X16?

975 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 349 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (74.8%), loss of osseointegration (13.5%), difficult to insert (1.6%) and fracture (1.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (80%) and distributor reports (20%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that GM Helix Implant,Ti,3.5X16 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.